Mutagenicity and genotoxicity of isatin in mammalian cells in vivo

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 719, Issue 1-2, 2011, Pages 47-51

  Cândido Bacani, Priscila de Matos ^a   Reis, Mariana Bisarro dos ^a   Serpeloni, Juliana Mara ^a   Calvo, Tamara Regina ^b   Vilegas, Wagner ^b   Varanda, Eliana Aparecida ^b   Cólus, Ilce Mara de Syllos ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Comet assay; Isatin; Mice; Micronucleus test

Indexed keywords

ISATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CELL; BONE MARROW CELL; COMET ASSAY; CONTROLLED STUDY; FEMALE; GENOTOXICITY; IN VIVO STUDY; LD 50; MALE; MICRONUCLEUS TEST; MOUSE; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BONE MARROW CELLS; COMET ASSAY; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; ISATIN; LEUKOCYTES; MALE; MICE; MICRONUCLEUS TESTS; MICROSCOPY, FLUORESCENCE; MUTAGENICITY TESTS; RETICULOCYTES; TIME FACTORS;

MAMMALIA; MUS;

EID: 78650581998     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2010.11.006     Document Type: Article

References (51)

1. Newman D.J., Cragg G.M., Snader K.M. Natural products as sources of new drugs over the period 1981-2002. J. Nat. Prod. 2003, 66:1022-1037.
2. Mothana R.A., Lindequist U., Gruenert R., Bednarski P.J. Studies of the in vitro anticancer, antimicrobial and antioxidant potentials of selected Yemeni medicinal plants from the island Soqotra, BMC complement. Altern. Med. 2009, 9. 10.1186/1472-6882-9-7.
3. Veiga Junior V.F., Pinto A.C., Maciel M.A.M. Plantas medicinais: cura segura?. Quím. Nova 2005, 28:519-528.
4. Beljanski M., Beljanski M.S. Selective inhibition of in vitro synthesis of cancer DNA by alkaloids of beta-carboline class. Exp. Cell Biol. 1982, 50:79-87.
5. Rodríguez A.M., Camargo J.R., García F.J.B. Actividad in vitro de la mezcla de alcaloides de Ervatamia coronaria (Jacq) Staff. Apocynaceae sobre amastigotes de Leishmania braziliensis. Rev. Bras. Farmacogn. 2008, 18:350-355.
6. Silva J.F.M., Garden S.J., Pinto A.C. The chemistry of isatins: a review from 1975 to 1999. J. Braz. Chem. Soc. 2001, 12:273-324.
7. Vine K.L., Matesic L., Locke J.M., Ranson M., Skropeta D. Cytotoxic and anticancer activities of isatin and its derivatives: a comprehensive review from 2000-2008. Anticancer Agents Med. Chem. 2009, 9:397-414.
8. Organization for Economic Co-operation and Development (OECD), OECD guideline for testing of chemicals, n° 423, Acute Oral Toxicity - Acute Toxic Class Method, 2001.
9. Medvedev A.E., Clow A., Sandler M., Glover V. Isatin: a link between natriuretic peptides and monoamines?. Biochem. Pharmacol. 1996, 52:385-391.
10. Sridhar S.K., Pandeya S.N., Stables J.P., Ramesh A. Anticonvulsant activity of hydrazones, Schiff and Mannich bases of isatin derivatives. Eur. J. Pharm. Sci. 2002, 16:129-132.
11. Pandeya S.N., Smitha S., Jyoti M., Sridhar S.K. Biological activities of isatin and its derivatives. Acta Pharm. 2005, 55:27-46.
12. Bhattacharya S.K., Acharya S.B. Further investigations on the anxiogenic effects of isatin. Biogenic Amines 1993, 9:453-463.
13. Hamaue N., Minami M., Kanamaru Y., Ishikura M., Yamazaki N., Saito H., Parvez S.H. Identification of isatin, an endogenous MAO inhibitor, in the brain of stroke-prone SHR. Biogenic Amines 1994, 10:99-110.
14. Sathisha M.P., Revankar V.K., Pai K.S.R. Synthesis, structure, electrochemistry, and spectral characterization of bis-isatin thiocarbohydrazone metal complexes and their antitumor activity against Ehrlich ascites carcinoma in Swiss albino mice. Met Based Drugs 2008, 10.1155/2008/362105.
15. Hamaue N., Minami M., Terado M., Hirafuji M., Endo T., Machida M., Hiroshige T., Ogata A., Tashiro K., Saito H., Parvez S.H. Comparative study of the effects of isatin, an endogenous MAO-inhibitor, and selegiline on bradykinesia and dopamine levels in a rat model of Parkinson's disease induced by the Japanese encephalitis virus. Neurotoxicology 2004, 25:205-213.
16. Anderson D, Bishop J.B., Garner R.C., Ostrosky-Wegman P., Selby P.B. Cyclophosphamide: review of its mutagenicity for an assessment of potential germ cell risks. Mutat. Res. 1995, 330:115-181.
17. Olfert E.D., Cross B.M., McWilliam A.A. Guide to the Care and Use of Experimental Animals 1993, Canadian Council on Animal Care, Ottawa. 2nd ed.
18. Organization for Economic Co-operation and Development (OECD), OECD guideline for the testing of chemicals, n° 474, Genetic Toxicology: Mammalian Erythrocyte Micronucleus Test, 1997.
19. Tice R.R., Agurell E., Anderson D., Burlinson B., Hartmann A., Kobayashi H., Miyamae Y., Rojas E., Ryu J.-C., Sasaki Y.F. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen. 2000, 35:206-221.
20. Hayashi M., MacGregor J.T., Gatehouse D.G., Adler I.-D., Blakey D.H., Dertinger S.D., Krishna G., Morita T., Russo A., Sutou S. In vivo rodent erythrocyte micronucleus assay. II. Some aspects of protocol design including repeated treatments, integration with toxicity testing, and automated scoring. Environ. Mol. Mutagen. 2000, 35:234-252.
21. Schmid W. The micronucleus test. Mutat. Res. 1975, 31:9-15.
22. Hayashi M., Morita T., Kodama Y., Sofuni T., Ishidate M. The micronucleus assay with mouse peripheral blood reticulocytes using acridine orange-coated slides. Mutat. Res. 1990, 245:245-249.
23. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 1988, 175:184-191.
24. da Silva J., de Freitas T.R.O., Marinho J.R., Speit G., Erdtmann B. An alkaline single-cell gel electrophoresis (comet) assay for environmental biomonitoring with native rodents. Genet. Mol. Biol. 2000, 23:241-245.
25. Nesslany F., Zennouche N., Simar-Meintières S., Talahari I., Nkili-Mboui E.N., Marzin D. In vivo comet assay on isolated kidney cells to distinguish genotoxic carcinogens from epigenetic carcinogens or cytotoxic compounds. Mutat. Res. 2007, 630:28-41.
26. Kobayashi H., Sugiyama C., Morikawa Y., Hayashi M., Sofuni T. A comparison between manual microscopic analysis and computerized image analysis in the single cell gel electrophoresis assay. MMS Commun. 1995, 3:103-115.
27. Manoharan K., Banerjee M.R. β-Carotene reduces sister chromatid exchanges induced by chemical carcinogens in mouse mammary cells in organ culture. Cell Biol. Int. Rep. 1985, 9:783-789.
28. Bast A., Chandler R.F., Choy P.C., Delmulle L.M., Gruenwald J., Halkes S.B.A., Keller K., Koeman J.H., Peters P., Przyrembel H., de Ree E.M., Renwick A.G., Vermeer I.T.M. Botanical health products, positioning and requirements for effective and safe use, Environ. Toxicol. Pharmacol. 2002, 12:195-211.
29. Santos J.L., Varanda E.A., Lima L.M., Chin C.M. Avaliação da atividade mutagênica da talidomida pelo teste de Ames. Rev. Eletr. Farm. 2007, 4:154-158.
30. Rodeiro I., Cancino L., González J.E., Morffi J., Garrido G., González R.M., Nuñez A., Delgado R. Evaluation of the genotoxic potential of Mangifera indica L. extract (Vimang), a new natural product with antioxidant activity. Food Chem. Toxicol. 2006, 44:1707-1713.
31. Fenech M., Holland N., Chang W.P., Zeiger E., Bonassi S. The human micronucleus project - an international collaborative study on the use of the micronucleus technique for measuring DNA damage in humans. Mutat. Res. 1999, 428:271-283.
32. Krishna G., Hayashi M. In vivo rodent micronucleus assay: protocol, conduct and data interpretation. Mutat. Res. 2000, 455:155-166.
33. Witte I., Plappert U., de Wall H., Hartmann A. Genetic toxicity assessment: employing the best science for human safety evaluation part III: the comet assay as an alternative to in vitro clastogenicity tests for early drug candidate selection. Toxicol. Sci. 2007, 97:21-26.
34. Burlinson B., Tice R.R., Speit G., Agurell E., Brendler-Schwaab S.Y., Collins A.R., Escobar P., Honma M., Kumaravel T.S., Nakajima M., Sasaki Y.F., Thybaud V., Uno Y., Vasquez M., Hartmann A. Fourth international workgroup on genotoxicity testing: results of the in vivo comet assay workgroup. Mutat. Res. 2007, 627:31-35.
35. Tweats D.J., Blakey D., Heflich R.H., Jacobs A., Jacobsen S.D., Morita T., Nohmi T., O'Donovan M.R., Sasaki Y.F., Sofuni T., Tice R. Report of the IWGT working group on strategies and interpretation of regulatory in vivo tests I. Increases in micronucleated bone marrow cells in rodents that do not indicate genotoxic hazards. Mutat. Res. 2007, 627:78-91.
36. Hayashi M., Tice R.R., MacGregor J.T., Anderson D., Blakey D.H., Kirsch-Volders M., Oleson F.B., Pacchierotti F., Romagna F., Shimada H., Sutou S., Vannier B. In vivo rodent erythrocyte micronucleus assay. Mutat. Res. 1994, 312:293-304.
37. Hartmann A., Agurell E., Beevers C., Brendler-Schwaab S., Burlinson B., Clay P., Collins A., Smith A., Speit G., Thybaud V., Tice R.R. Recommendations for conducting the in vivo alkaline comet assay. Mutagenesis 2003, 18:45-51.
38. Boone C.W., Kelloff G.J., Malone W.E. Identification of candidate cancer chemo-preventive agents and their evaluation in animal models and human clinical trials: a review. Cancer Res. 1990, 50:2-9.
39. Argmann C.A., Chambon P., Auwerx J. Mouse phenogenomics: the fast track to " systems metabolism" Cell Metab. 2005, 2:349-360.
40. Henriques J.A.P., Moreno P.R.H., Von Poser G.L., Querol C.C., Henriques A.T. Genotoxic effect of alkaloids. Mem. Inst. Oswaldo Cruz 1991, 86:71-74.
41. Taira Z., Kanzawas S., Dohara C., Ishida S., Matsumoto M., Sakiya Y. Intercalation of six beta-carboline derivatives into DNA. Jpn. J. Toxicol. Environ. Health 1997, 43:83-91.
42. Ansah C., Khan A., Gooderham N.J. In vitro genotoxicity of the West African anti-malarial herbal Cryptolepis sanguinolenta and its major alkaloid cryptolepine. Toxicology 2005, 208:141-147.
43. Foureman P., Mason J.M., Valencia R., Zimmering S. Chemical mutagenesis testing in Drosophila. IX. Results of 50 coded compounds tested for the national toxicology program. Environ. Mol. Mutagen. 1994, 23:51-63.
44. Rannung U., Bramstedt H., Nilsson U. The presence of genotoxic and bioactive components in indigo dyed fabrics-a possible health risk?. Mutat. Res. 1992, 282:219-225.
45. Bacchi A., Carcelli M., Pelagatti P., Pelizzi G., Rodriguez-Arguelles M.C., Rogolino D., Solinas C., Zani F. Antimicrobial and mutagenic properties of organotin (IV) complexes with isatin and N-alkylisatin bisthiocarbonohydrazones. J. Inorg. Biochem. 2005, 99:397-408.
46. Vilar J.B., Ferreira F.L., Ferri P.H., Guillo L.A., Chen Chen L. Assessment of the mutagenic, antimutagenic and cytotoxic activities of ethanolic extract of araticum (Annona crassiflora Mart. 1841) by micronucleus test in mice. Braz. J. Biol. 2008, 68:141-147.
47. Cane A., Tournaire M.-C., Barritault D., Crumeyrolle-Arias M. The endogenous oxindoles 5-hydroxyoxindole and isatin are antiproliferative and proapoptotic. Biochem. Biophys. Res. Commun. 2000, 276:379-384.
48. Igosheva N., Lorz C., O'Conner E., Glover V., Mehmet H. Isatin, an endogenous monoamine oxidase inhibitor, triggers a dose- and time-dependent switch from apoptosis to necrosis in human neuroblastoma cells. Neurochem. Int. 2005, 47:216-224.
49. Matheus M.E., Violante F.A., Garden S.J., Pinto A.C., Fernandes P.D. Isatins inhibit cyclooxygenase-2 and inducible nitric oxide synthase in a mouse macrophage cell line. Eur. J. Pharmacol. 2007, 556:200-206.
50. Vine K.L., Locke J.M., Ranson M., Benkendorff K., Pyne S.G., Bremner J.B. In vitro cytotoxicity evaluation of some substituted isatin derivatives. Bioorg. Med. Chem. 2007, 15:931-938.
51. Hou L., Ju C., Zhang J., Song J., Ge Y., Yue W. Antitumor effects of isatin on human neuroblastoma cell line (SH-SY5Y) and the related mechanism. Eur. J. Pharmacol. 2008, 589:27-31.